Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Hypertension. 2016 Dec 19;69(2):236–242. doi: 10.1161/HYPERTENSIONAHA.116.08436

Table 1.

Baseline characteristics in 229 postmenopausal women undergoing coronary blood flow (CBF) response to intracoronary acetylcholine

Variable CMD (n=133) No CMD (n=88)
Age (years) 57 (IQR 51–65) 58 (53–67)
Diabetes 6.0% (8) 3.4% (14)
Hypertension 50.0% (66) 46.1% (41)
Hyperlipidemia 63.6% (84) 60.9% (53)
Body mass index
(kg/m2)		 28.1 (IQR 24.2,31.9) 27.2 (IQR 23.8,31.6)
Neutrophils (×10^9) 3.4(2.8,4.3) 3.8 (3.0,4.7)
hsCRP (mg/L) 0.6 (0.3,2.0) 0.4(0.2,1.6)
Uric acid (mg/dL) 4.7(4.1, 5.7) 4.3 (3.5,5.5)
Antihypertensive use 20.0% (27) 21.3%(19)
Follow-up duration
(years)		 6.2 (3.8, 10.1) 6.5 (3.2,11.5)

CMD = coronary microvascular dysfunction; hsCRP = high sensitivity C-reactive protein